Prognostic Value of the Osaka Prognostic Score for One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Cohort Study
Journal of Clinical Medicine · 12.06.2026 · 15 (12) · 4561
DOI: 10.3390/jcm15124561 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.06.2026. Verfasst von Çağatay Önal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Private Gazi Hospital, 35230 İzmir, Türkiye. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The Osaka Prognostic Score (OPS) has demonstrated prognostic value in various cardiovascular settings. However, its role in predicting long-term outcomes in patients with ST-segment elevation myocardial infarction (STEMI) remains insufficiently explored. This study aimed to investigate the association between baseline OPS and one-year all-cause mortality in patients presenting with STEMI.
Methods
OPS was calculated in 463 consecutive patients with STEMI at hospital admission. The primary endpoint was one-year all-cause mortality. Clinical, laboratory, echocardiographic, and angiographic variables were analyzed for each patient.
Results
During one-year follow-up, patients who died exhibited significantly higher OPS values compared with survivors (1.70 ± 0.89 vs. 0.38 ± 0.65; p < 0.001). In multivariable logistic regression analysis, lower hemoglobin levels (OR 0.780, 95% CI 0.630–0.967; p < 0.001) and left ventricular ejection fraction (OR 0.948, 95% CI 0.902–0.997; p = 0.037) were associated with an increased risk of mortality whereas both the GRACE risk score (OR 2.653, 95% CI 1.345–3.987; p < 0.001) and OPS (OR 1.536, 95% CI 1.102–2.234; p = 0.001) were positively associated with mortality. The combined GRACE + OPS logistic regression model demonstrated significantly better discriminative performance for predicting 1-year mortality compared with the GRACE-only model (AUC: 0.836 vs. 0.761). DeLong analysis confirmed that the addition of OPS significantly improved predictive accuracy (ΔAUC = 0.075, 95% CI: 0.015–0.136; p = 0.014).
Conclusions
Baseline OPS is independently associated with one-year all-cause mortality in patients with STEMI and may have potential utility in this group of patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Private Gazi Hospital, 35230 İzmir, Türkiye.
- Department of Cardiology, Bakırköy Dr. Sadi Konuk Education and Research Hospital, 34147 İstanbul, Türkiye.
- Department of Cardiology, Private Beylikdüzü Kolan Hospital, 34528 İstanbul, Türkiye.
- Department of Cardiology, Private Medical Point Hospital, 35575 İzmir, Türkiye.
- Department of Cardiology, Cerrahpaşa Medical Faculty, İstanbul University, 34098 İstanbul, Türkiye.
ORCID-Profile: Çağatay Önal, Cennet Yıldız, Yasin Yüksel
Zitieren
APA
Önal, Ç., Yıldız, C., Yüksel, Y., Ayça, B., Taşkın, U., & Katkat, F. (2026). Prognostic Value of the Osaka Prognostic Score for One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Cohort Study. Journal of Clinical Medicine, 15(12), 4561. https://doi.org/10.3390/jcm15124561
Vancouver
Önal Ç, Yıldız C, Yüksel Y, Ayça B, Taşkın U, Katkat F. Prognostic Value of the Osaka Prognostic Score for One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Cohort Study. Journal of Clinical Medicine. 2026;15(12):4561. doi:10.3390/jcm15124561
BibTeX
@article{nal2026,
author = {Önal, Çağatay and Yıldız, Cennet and Yüksel, Yasin and Ayça, Burak and Taşkın, Uğur and Katkat, Fahrettin},
title = {Prognostic Value of the Osaka Prognostic Score for One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4561},
doi = {10.3390/jcm15124561}
}
EUVIMED